Researchers have identified YAP and TAZ as crucial regulators of macrophage-mediated pulmonary inflammation and fibrosis, ...

A new inhalable gene therapy for cystic fibrosis (CF) has entered Phase I clinical trials, a major milestone on the journey ...

The safety of three therapeutic methods, each featuring electromagnetic navigation bronchoscopy-guided microwave ablation, was established in patients with multiple bilateral ground-glass opacities, ...

Respiratory diseases are a challenging problem to treat. Inhalable medicines are a promising solution that depends on the ...

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

Qureight Ltd, a Core Imaging Laboratory developing deep-learning image analytics, and Vicore Pharma, a clinical-stage biopharmaceutical company unlocking the potential of angiotensin II type 2 ...

Medically reviewed by William Truswell, MD Clubbed nails, also known as digital clubbing or Hippocratic fingers, describe a ...

The "Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast - 2034" report has been added tAndMarkets.com's offering.The report delivers an in-depth understanding of the Cough in ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

ILD score, reflecting the severity of pulmonary fibrosis, was evaluated in the same six lung fields based on the percentage of ... In many low-income settings, access to advanced diagnostic tools such ...

A person’s chest may hurt when they cough as a result of muscle strain from coughing. However, it can also be a sign of pleurisy, pneumonia, and other serious conditions. In many cases ...